N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide

C14H17N5O3S — CID 655678

IUPACN-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide
SMILESCCCCn1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2
InChIInChI=1S/C14H17N5O3S/c1-2-3-6-19-14(16-17-18-19)23-8-13(20)15-10-4-5-11-12(7-10)22-9-21-11/h4-5,7H,2-3,6,8-9H2,1H3,(H,15,20)
InChIKeyRLQBEUGCQYIXBG-UHFFFAOYSA-N
MW335.39 g/mol
LogP1.93
Rot. Bonds7

About N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide

N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide (PubChem CID 655678) has the molecular formula C14H17N5O3S and a molecular weight of 335.39 g/mol. Its IUPAC name is N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide.

Molecular Properties

Compound NameN-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide
PubChem CID655678
Molecular FormulaC14H17N5O3S
Molecular Weight335.39 g/mol
Exact Mass335.11
IUPAC NameN-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide
SMILESCCCCn1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2
InChIInChI=1S/C14H17N5O3S/c1-2-3-6-19-14(16-17-18-19)23-8-13(20)15-10-4-5-11-12(7-10)22-9-21-11/h4-5,7H,2-3,6,8-9H2,1H3,(H,15,20)
InChIKeyRLQBEUGCQYIXBG-UHFFFAOYSA-N
XLogP1.93
TPSA91.16 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500335.39
LogP ≤ 51.93
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(1-methyltetrazol-5-yl)sulfanylacetamide
CID 861219
N-(1,3-benzodioxol-5-yl)-2-(1-methyltetrazol-5-yl)sulfanylacetamide
CID 861220
N-(1,3-benzodioxol-5-yl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]sulfanylacetamide
CID 3212977
2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(4-methoxyphenyl)acetamide
CID 3228979
2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(1,3-benzodioxol-5-yl)propanamide
CID 16303108
N-Benzo[1,3]dioxol-5-yl-2-(5-benzyl-4-ethyl-4H-[1,2,4]triazol-3-ylsulfanyl)-acetamide
CID 655999
N-Benzo[1,3]dioxol-5-yl-2-(1-cyclopentyl-1H-tetrazol-5-ylsulfanyl)-acetamide
CID 647456
2-(1-Benzo[1,3]dioxol-5-yl-1H-tetrazol-5-ylsulfanyl)-N-(2-methoxy-phenyl)-acetamide
CID 650626
2,5-dioxo-1-phenylpyrrolidin-3-yl N'-1,3-benzodioxol-5-yl-N-methylcarbamimidothioate
CID 652180
2-(1-Benzo[1,3]dioxol-5-yl-1H-tetrazol-5-ylsulfanyl)-N-(2,5-dimethoxy-phenyl)-acetamide
CID 653731
N-Benzo[1,3]dioxol-5-ylmethyl-2-[1-(3-methoxy-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide
CID 654256
N-(3,5-Dimethoxy-phenyl)-2-(1-ethyl-1H-tetrazol-5-ylsulfanyl)-acetamide
CID 655782

Frequently Asked Questions

What is the IUPAC name of N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide?
The IUPAC name of N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide (CID 655678) is N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide.
What is the SMILES notation for N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide?
The canonical SMILES for N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide is CCCCn1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2.
What is the InChIKey of N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide?
The InChIKey is RLQBEUGCQYIXBG-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H17N5O3S/c1-2-3-6-19-14(16-17-18-19)23-8-13(20)15-10-4-5-11-12(7-10)22-9-21-11/h4-5,7H,2-3,6,8-9H2,1H3,(H,15,20).
What are the key properties of N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide?
N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide has a molecular weight of 335.39 g/mol, XLogP of 1.93, 7 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1,3-benzodioxol-5-yl)-2-(1-butyltetrazol-5-yl)sulfanylacetamide is sourced from PubChem (CID 655678), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).